Skip to main content
. 2012 Sep 5;67(1):2–7. doi: 10.1038/ejcn.2012.121

Table 1. Baseline demographic characteristics of the modified intent-to-treat analysis samplea.

  Placebo (n=35) CG 4.5 g/day (n=33) CG 1.5 g/day (n=32) CG combination (n=30)
Age (years) 52.0±11.3 49.1±11.2 50.9±10.3 50.7±9.8
         
Gender [n (%)]
 Male 14 (40.0%) 17 (51.5%) 13 (40.6%) 16 (53.3%)
 Female 21 (60.0%) 16 (48.5%) 19 (59.4%) 14 (46.7%)
         
Race/ethnicity [n (%)]
 Caucasian 31 (88.6%) 29 (87.9%) 28 (87.5%) 19 (63.3%)
 Black 3 (8.6%) 3 (9.1%) 3 (9.4%) 8 (26.7%)
 Asian 0 (0.0%) 1 (3.0%) 1 (3.1%) 3 (10.0%)
 Native American 1 (2.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
         
Weight (kg) 78.7±12.8 84.2±15.5 79.7±14.0 81.7±14.2
Height (cm) 168.4±7.8 171.9±10.6 169.3±8.0 170.4±8.3
BMI (kg/m2) 27.7±3.5 28.4±4.3 27.6±3.2 28.0±3.3
SBP (mm Hg) 115.8±10.8 115.2±14.0 119.8±13.9 119.8±14.9
DBP (mm Hg) 73.1±9.4 76.3±12.1 76.3±7.5 77.6±10.4

Abbreviations: BMI, body mass index; CG, chitin-glucan; DBP, diastolic blood pressure; SBP, systolic blood pressure.

a

Data are mean±s.d. or number (%).